Moderna Therapeutics scores $450 mln

Cambridge Mass.-based biotech firm Moderna Therapeutics has closed $450 million in funding. The backers in this round include Viking Global Investors, Invus, RA Capital Management, Wellington Management Company, AstraZeneca and Alexion Pharmaceuticals.

6 January 2015•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail